"Our solution tracks disease progression through continuous or frequent breath monitoring and derives valuable insights for timely treatment adjustments"
An Israel-based healthcare technology company, Breath of Health announces clinical studies in the US for its non-invasive, breath-based pathogen detection technology.
The association is to evaluate all types of Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Bladder Cancer, Colorectal Cancer, Cervical Cancer by evaluating all kinds of organic compounds analyzed by our state-of-the-art AI platforms allowing quick development of breath diagnostics...
Longevity Biotech Fellowship -- a community for people to come together to build revolutionary longevity projects.
Breath of Health Ltd (BOH) is proud to collaborate with CSIR-Central Electronics Engineering Research Institute, CSIO-Central Scientific Instruments Organization which is a contemporary Indian Government R&D organization with a dynamic network of 37 National LaboratoriesRead More
BOH has completed its ISO13485:2016 certificate and the Declaration of Conformity CE, based on its COVID19 clinical trials in Europe and Israel. Clinical trials agreement for cancer diagnostics signed with two hospitals in Israel Rambam Healthcare Campus and Ziv Medical Centre.Israeli company Breath of Health (BOH) pharma develops a blow test that can replace #PCR tests
Israeli company Breath of Health (BOH) pharma develops a blow test that can replace #PCR tests. This system is capable of identifying other outbreaks,' CEO Arie Laor says, in addition to diabetes and cancers. Non-Invasive breath based detection of cancer, diabetes, COVID19Israeli company Breath of Health (BOH) pharma develops a blow test that can replace